It is classified as a triple incretin receptor agonist, meaning it simultaneously targets three hormone receptors: glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors
Certificate of Analysis (CoA) available for every batch
Effects of the gut microbiota on host adiposity are modulated by the short-chain fatty-acid binding G protein-coupled receptor, Gpr41
BPC-157 creates this environment by: Increasing vascularization in the treated area, ensuring oxygen and nutrient delivery Reducing inflammation that could otherwise impair cell survival Upregulating growth factor receptors on local cells, making them more responsive to PRP-derived signals In my practice, patients receiving PRP or stem cell injections for complex musculoskeletal conditions are routinely offered concurrent BPC-157 to maximize outcomes
Coughlin, M.D., 2013 BBRF Young Investigator